Abstract
Quantitative analysis of total gangliosides and of ganglioside composition by HPTLC has been carried out on the gray matter of frontal cerebral cortex of six brains from Down’s syndrome (DS) adults, six age-matched controls, six Alzheimer’s disease (AD) adults, and six controls matched for age with the AD brains, as well as on three DS and six control cerebellum specimens. In addition, the analyses were carried out on specimens of corpus callosum of five adult DS and five control brains. No abnormalities were found in the gangliosides of DS corpus callosum. In DS frontal cortex, the concentration of total gangliosides was reduced, and there was a decrease in the fraction of GT1b and GD1b′ and an increase in those of GT1a′ GD3′ GM1 and GM2; the ratio of total b-series to a-series gangliosides was decreased. Very similar abnormalities were found in the gangliosides of DS cerebellum. In AD frontal cortex, by contrast, the total gangliosides and their composition were normal by comparison with agematched controls, with the minor exception of reductions in the fractions of GQ1b and GT1L. It is concluded that abnormalities in gangliosides exist in the brain in DS that are unrelated to AD-type pathology and may reflect developmental disturbances.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- DS:
-
Down’s syndrome
- NANA:
-
N-Acetylneuraminic acid
- ChAT:
-
Choline acetyltransferase
- AD:
-
Alzheimer’s disease
- HPTLC:
-
High-performance thinlayer chromatography
References
Ando S., Chang N.-C., and Yu R. K. (1978) High-performance thin-layer chromatography and densitometric determination of brain ganglioside composition of several species.Anal. Biochem. 89, 437–450.
Ando S. (1983) Gangliosides in the nervous system.Neurochem. Int. 5, 507–537.
Baker R. E. (1988) Gangliosides as cell-adhesion factors in the formation of selective connections within the nervous system.Prov. Brain Res. 73, 491–508.
Bowen D. M., Smith C. B., White P., Flack R. H. A., Carrasco L. H., Gedye J. L., and Davison A. N. (1987) Chemical pathology of the organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains.Brain,100, 427–453.
Brooksbank B. W. L. and Balázs R. (1988) Development and aging of the brain in a common human aneuploidy—Down’s syndrome,Handbook of Human Growth and Developmental Biology (Meisami E. and Timiras P. S., eds.), vol. I, part C, pp. 21–44, CMC, Boca Raton, FL.
Brooksbank B. W. L., and Martinez, M. (1989) Lipid abnormalities in the brain in adult Down’s syndrome and Alzheimer’s disease.Molec. Chem. Neuropathol.,11, ...
Brooksbank B. W. L., Walker D., Balázs R., and Jørgensen O. S. (1989) Neuronal maturation in the foetal brain in Down’s syndrome.Early Hum. Dev. 18, 237–246.
Candy J. M., Perry E. K., Perry R. M., Court J. A., Oakley A. E., and Edwardson J. A. (1986) The current status of the cortical cholinergic system in Alzheimer’s disease and Parkinson’s disease.Prog. Brain Res. 65, 105–132.
Chan K. F. (1987) Ganglioside-modulated protein phosphorylation. Partial purification and characterization of a ganglioside-stimulated protein kinase in brain.J. Biol. Chem. 262, 5248–5255.
Cherayil G. D. (1969) Estimation of glycolipids in four selected lobes of human brain in neurological diseases.J. Neurochem. 16, 913–920.
Collerton D. (1986) Cholinergic function and intellectual decline in Alzheimer’s disease.Neuroscience 19, 1–28.
Coyle J. T., Oster-Granite M. L., and Gearhart J. D. (1986) The neurobiologic consequences of Down’s syndrome.Brain Res. Bull. 16, 773–787.
Crino P. B., Ullman M. D., Vogt B. A., Bird E. D., and Volicer L. (1989) Brain gangliosides in dementia of the Alzheimer type.Arch. Neurol. 46, 398–401.
DeKosky S. T. and Bass N. H. (1982) Aging, senile dementia, and the intralaminar microchemistry of cerebral cortex.Neurology 32, 1227–1233.
Fonnum F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase.J. Neurochem. 24, 407–409.
Ghidoni R., Sonnino S., Tettamanti G., Baumann N., Reuter G., and Schauer, R. (1980) Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid.J. Biol. Chem. 255, 6990–6995.
Gorio A. (1986) Ganglioside enhancement of neuronal differentiation, plasticity and repair.CRC Crit. Rev. Clin. Neurobiol. 2, 241–296.
Hakomori S.-I. (1981) Glycospingolipids in cellular interaction, differentiation and oncogenesis.Annu. Rev. Biochem. 50, 733–764.
Hardy, J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., Perdahl E., Wester P., and Winblad B. (1985) Transmitter deficits in Alzheimer’s disease.Neurochem. Int. 4, 545–573.
Harth S., Dreyfus H., Urban P. F., and Mandel P. (1978) Direct thin-layer chromatography of gangliosides of a total lipid extract.Anal. Biochem. 86, 543–551.
Kraĉun I., Rösner H., Cosovič C., and Stavljenič A. (1984) Topographical atlas of the gangliosides of the adult human brain.J. Neurochem. 43, 979–989.
Kundu S. K. (1981) Thin-layer chromatography of neutral glycosphingolipids and gangliosides.Methods Enzymol. 72, 185–204.
Ledeen R. W. (1983) Gangliosides,Handbook of Neurochemistry, Metabolism in the Nervous System 2nd ed., vol. 3 (Lajtha A., ed.), pp. 41–90, Plenum, New York.
Ledeen R. W. (1984) Biology of gangliosides: Neuritogenic and neuronotrophic properties.J. Neurosci. Res. 12, 147–159.
Ledeen R. W. and Yu R. K. (1982) Ganglioside structure, isolation and analysis.Methods Enzymol. 83, 139–191.
Leon A., Facci L., Toffano G., Sonnino S., and Tettamanti G. (1981) Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside.J. Neurochem. 37, 350–357.
McCoy E. E. and Sneddon J. M. (1983) Cell biological aspects of Down’s syndrome.Adv. Cell. Neurobiol. 4, 249–261.
Majocha R. E., Jungalwala F. B., Rodenrys A., and Marotta C. A. (1989) Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides.J. Neurochem. 53, 953–961.
Mann D. M. A. (1988) The pathological association between Down syndrome and Alzheimer disease.Mech. Ageing Dev. 43, 99–136.
Miettinen T. and Takki-Luukainen I. T. (1959) Use of butyl acetate in determination of sialic acid.Acta Chem. Scand. 13, 856–858.
Oliver C. and Holland A. J. (1986) Down’s syndrome and Alzheimer’s disease: A review.Psychol. Med. 16, 307–322.
Rösner H. (1982) Ganglioside changes in the chicken optic lobes as biochemical indicators of brain development and maturation.Brain Res. 236, 49–61.
Scott B. S., Becker L. E., and Petit T. L. (1983) Neurobiology of Down’s syndrome.Prog. Neurobiol. 21, 199–237.
Segler-Stahl K., Webster J. C., and Brunngraber E. G. (1983) Changes in the concentration and composition of human brain gangliosides with aging.Gerontology 29, 161–168.
Sinex F. M. and Merrill C. R. (eds.) (1982) Alzheimer’s disease, Down’s syndrome and aging.Ann. NY Acad. Sci. 396.
Sorbi S., Piacentini S., and Amaducci L. (1987) Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer’s disease.Gerontology 33, 197–202.
Suzuki K. (1965) The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, post-mortem changes and the effect of formalin preservation.J. Neurochem. 12, 629–638.
Suzuki K., Katzman R., and Korey S. (1965) Chemical studies on Alzheimer’s disease.J. Neuropathol. Exp. Neurol. 24, 211–224.
Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.Biochim. Biophys. Acta 24, 604–611.
Tomlinson, B. E. (1980) The structural and quantitative aspects of the dementias,Biochemistry of Dementia (Roberts P. J., ed.), pp. 25–52, Wiley, New York.
Ueno K., Ando S., and Yu R. K. (1978) Gangliosides of human, cat, and rabbit spinal cords and cord myelin.J. Lipid Res. 19, 863–871.
Urban P. F., Harth S., Freysz L., and Dreyfus H. (1980) Brain and retinal ganglioside composition from different species determined by TLC and HPTLC,Structure and Function of Gangliosides (Svennerholm L., Mandel P., Dreyfus H., and Urban P. F., eds.), pp. 149–157, Plenum, New York.
Vanier M. T., Holm M., Ohman R., and Svennerholm L. (1971) Developmental profiles of gangliosides in human and rat brain.J. Neurochem. 18, 581–592.
Wisniewski K. E., Wisniewski H. M., and Wen G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome.Ann. Neurol. 17, 278–282.
Yates A. J. (1986) Gangliosides in the nervous system during development and regeneration.Neurochem. Pathol. 5, 309–329.
Yavin E. and Yavin Z. (1979) Ganglioside profiles during neural tissue development, acquisition in the prenatal rat brain and cerebral cell cultures.Dev. Neurosci. 2, 25–37.
Zanetta J. P., Vitiello F., and Vincendon G. (1980) Gangliosides from rat cerebellum: Demonstration of considerable heterogeneity using a new solvent for thin layer chromatography.Lipids 15, 1055–1061.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brooksbank, B.W.L., McGovern, J. Gangliosides in the brain in adult Down’s syndrome and Alzheimer’s disease. Molecular and Chemical Neuropathology 11, 143–156 (1989). https://doi.org/10.1007/BF03160048
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03160048